SOJOURN

This brand name is authorized in Canada, Ecuador, France, Hong Kong, Croatia, Poland, Romania, Singapore, Turkey, United States, South Africa

Active ingredients

The drug SOJOURN contains one active pharmaceutical ingredient (API):

1 Sevoflurane UNII 38LVP0K73A - SEVOFLURANE

Sevoflurane is used as an inhalational anaesthetic for induction and maintenance of general anesthesia. As with all other inhalation agents sevoflurane depresses cardiovascular function in a dose related fashion. In patients with normal intracranial pressure (ICP), sevoflurane had minimal effect on ICP and preserved CO2 responsiveness. Read about Sevoflurane

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01AB08	Sevoflurane	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AB Halogenated hydrocarbons
Discover more medicines within N01AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02307766
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28862-05-09
Country: FR	Base de données publique des médicaments	Identifier(s): 60654271
Country: HK	Department of Health Drug Office	Identifier(s): 56752
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-382308710
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100041869
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67161001, W67161002
Country: SG	Health Sciences Authority	Identifier(s): 14780P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699587523112
Country: US	FDA, National Drug Code	Identifier(s): 66794-012
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/2.1/0098